Healthy Extracts Inc (QB) (HYEX) Quote

$HYEX Healthy Extracts Reports Record Q3 2024; Issues Guidance for 20%+ Growth and Positive Cash Flow for Full Year 2024

https://www.accesswire.com/941417/healthy-extracts-reports-record-q3-2024-issues-guidance-for-20-growth-and-positive-cash-flow-for-full-year-2024

Net revenue up 21% year-over-year to record third-quarter high.

Achieved fourth consecutive positive cash flow quarter while still investing in future growth.

Growth in subscription-based sales generating an expanding recurring revenue stream.

Record increase in subscriptions driving greater customer lifetime value (CLV).

Outlook remains on track for more than 20% revenue growth in 2024, exceeding $3 million, and generate cash flow positive for the year.

LAS VEGAS, NV / ACCESSWIRE / November 12, 2024 / Healthy Extracts Inc. (OTCQB:HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the three and nine months ended September 30, 2024. All comparisons are to the year-ago period unless otherwise noted.

Q3 2024 Financial Highlights

Net revenue increased 21% to $745,000, a record for a third quarter, which was driven primarily by consumer sales growth and increased subscription-based revenue.

Gross profit increased 22% to $602,000 with gross margin up 50 basis points to 80.9% due to improved manufacturing efficiency and product mix.

Operating expenses decreased 31% to $517,000.

Reduced outstanding debt by $97,000, which brought the total debt reduction over the past two quarters to $205,000 and enabling additional capital to be applied to growth initiatives.

Net income totaled $355,000 or $0.12 per basic and diluted share, improving from a loss of $248,000 in the same year-ago period. The increase was primarily due to a change in fair value on derivative expense. Excluding expenses related to potential acquisitions and equity offerings, regulatory compliance, stock-based compensation, change in fair value of derivative expense and interest, net income in the third quarter of 2024 totaled $117,000 or $0.04 per basic and diluted share.

Amazon "Subscribe & Save" customers at September 30, 2024 increased 63% year-over-year to a record number of subscribers. Direct-to-consumer subscription customers (excluding Amazon) at September 30, 2024 increased 97% year-over-year. Subscription growth helps reduce customer acquisition costs, increases traction, and provides greater visibility into future revenue.

Management Commentary

"In Q3, we achieved another quarter of record-breaking revenue along with additional margin improvements and debt reduction," commented Healthy Extracts president, Duke Pitts. "This strong performance was driven by the sale of industry-leading products through our well-developed and diverse marketing channels-especially direct-to-consumer.

"The results also reflect how we achieved record-breaking Amazon sales in July and August, with this resulting from effectively targeted sales and marketing efforts for Prime Day, as well as record demand for our Amazon ‘Subscribe & Save' offerings.

"We also maintained a top three position among more than 100 competitors in Amazon's popular Citrus Bergamot category. We're looking forward to strong Black Friday and Cyber Monday events coming up later this month that we expect will take our Amazon sales to the next level.

"Given the tremendous success of our Amazon ‘Subscribe & Save' program, in July we introduced a 20% discount on monthly subscriptions on our direct-to-consumer eCommerce website, replacing our traditional Buy-2-Get-1 offers. This new offering has been well received, resulting in notable growth in subscription sign-ups.

"We see this new program helping to boost our sales and margins, as well as enable greater customer long-term retention rates. We estimate our subscription-based revenue is quickly approaching nearly a third of our overall revenue run-rate, with this supporting a significant increase in overall customer lifetime value or CLV.

"Now with our strongest fundamentals to date, including a streamlined capitalization structure, manageable debt levels, and four consecutive quarters of positive cash flow, our company is positioned exceptionally well.

"Despite navigating limited working capital due to challenging financial markets, we have maintained a consistent growth trajectory with a compound annual growth rate of approximately 25% over the last three years. Based on typical industry valuation multiples applied just to our Customer Lifetime Value (CLV), we believe our current market valuation is highly undervalued.

"For the rest of the year and into the next, we expect to continue to strengthen our top-line growth, profitability, and market share, especially as our addressable markets continue to expand. Our consistent growth momentum with our retail customers positions us well for the successful launch of new products that we're planning to roll out in the current fourth quarter. We are also in the best-ever position for making strategic, accretive acquisitions that would further accelerate our growth.

"The launch of these new products will benefit from the broad market channels we have strategically built and invested in over recent years. We believe these investments have proven to be the most effective way to create significant shareholder value. The continued pursuit of this strategy remains our top priority. Given our momentum coming into the fourth quarter, we expect to report record revenue and positive cash flow for the year, with this setting the stage for accelerated growth in 2025."

Financial Outlook

For the remainder of 2024, the company expects to remain on track for another year of record revenue at more than $3.0 million, representing a 20%+ year-over-year gain, and generate positive cash-flow for the year. New product introductions are expected to continue laying the way for stronger growth and greater profitability excluding non-cash expenses.

Product Outlook

Healthy Extracts' top brand ambassador and renowned fitness expert, Whitney Johns, is preparing to launch WHITNEY JOHNS™ NUTRITION on-the-go gel packs for COLLAGEN (anti-aging) in the first quarter of 2025. These products will be based on Healthy Extracts' exclusive oral delivery system and proprietary formulations.

The company is also planning to launch in the first quarter of 2025 its new BergaMet MYNUS sugar blocker, which is specially formulated to reduce up to 42% of the sugar impact from meals. The MYNUS on-the-go gel-packs will be made available under the company's exclusive U.S. and Canadian licensing and manufacturing agreement with Gelteq.

Q3 2024 Financial Summary

Net revenue in the third quarter of 2024 increased 21% to $745,000 from $614,000 in the same year-ago quarter, primarily due to consumer sales growth and increased subscription-based revenue.

Gross profit totaled $602,000 or 80.9% of net revenue as compared to $493,000 or 80.4% of net revenue in the same year-ago quarter. The 50 basis points increase in gross margin was the result of manufacturing efficiency and more favorable product mix.

Operating expenses decreased 31% to $517,000 as compared to $754,000 in the same year-ago quarter. The decrease in operating expenses was primarily due to one-time expenses in the year-ago quarter related to the company's planned uplist to Nasdaq and issuance of options and warrants that did not reoccur in the third quarter of 2024, and to a lesser extent the reduction in general operating expense in the third quarter of 2024.

Net income totaled $354,000 or $0.12 per basic and diluted share, as compared to a net loss of $248,000 or $(0.09) per basic and diluted share in the same year-ago period.

Excluding expenses related to planned acquisitions and public offerings, regulatory compliance, stock-based compensation, the change in fair value of derivative expense and interest expense, net income in the third quarter of 2024 totaled $117,000 or $0.04 per basic and diluted share versus net income of $33,000 or $0.01 per basic and diluted share.

First Nine Months of 2024 Financial Summary

Net revenue in the first nine months of 2024 increased 29% to a record $2.3 million compared to $1.8 million in the same year-ago period, primarily due to product line and distribution channel expansion.

Gross profit totaled $1.5 million or 63.9% of net revenue as compared to $1.1 million or 58.1% of net revenue in the same year-ago period. The increase in gross margin was a result of product mix sold as well as decreases in manufacturing and freight costs.

Operating expenses decreased 50% to $1.5 million compared to $3.0 million in the same year-ago period. The decrease in operating expenses was primarily due to one-time expenses in the same year-ago period related to the company's planned uplist to a Nasdaq and the issuance of options and warrants that did not reoccur in the 2024, and to a lesser extent the reduction in general operating expense in 2024.

Net loss totaled $394,000 or $(0.13) per basic and diluted share, compared to a loss of $2.1 million or $(0.72) per basic and diluted share in the same year-ago period. The improvement in net loss was primarily due to the same factors that drove improvement in the third quarter of 2024.

Excluding expenses related to the potential acquisitions and a public offering, regulatory compliance, stock compensation, change in fair value on derivative and interest expense, net income totaled $139,000 or $0.05 per basic and diluted share versus a net loss of $480,000 or $(0.16) per basic and diluted share in the same year-ago period.

$HYEX Healthy Extracts Expects to Report Record Third Quarter 2024, with Net Revenue Up More than 20%

https://www.accesswire.com/932595/healthy-extracts-expects-to-report-record-third-quarter-2024-with-net-revenue-up-more-than-20

Strong Growth in Subscription-Based Recurring Revenue Continues for Healthy Extracts as Category Top Three Amazon Seller

LAS VEGAS, NV / ACCESSWIRE / October 17, 2024 / Healthy Extracts Inc. (OTCQB:HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported preliminary record results for the third quarter ended September 30, 2024.

Net revenue is expected to exceed $740,000, a record for a third quarter, up more than 20% compared to the same year-ago quarter.

Gross margin for the quarter is expected to exceed 80%, driving positive operating cash flow and net profitability.

"In Q3, we achieved another quarter of record-breaking revenue, continued margin improvements, and further debt reduction, with this driven by robust performance in our direct-to-consumer channels," stated Healthy Extracts president, Duke Pitts. "This consistent growth momentum with our key retail customers positions us for the successful launch of new products we are planning to introduce in the current quarter."

The company generated record sales on Amazon in July, primarily as a result of its focused sales and marketing efforts for Prime Day and increased demand for its "Subscribe & Save" offers. During the quarter, the company continued to rank as a top three seller of Citrus Bergamot on Amazon among more than 100 competitors.

The company's products feature the only heart health supplement distributed in North America containing Citrus Bergamot SuperFruit™, which has the highest known concentration of polyphenols and flavonoids.

Given the success with Amazon's "Subscribe and Save," in July Healthy Extracts replaced its traditional buy-2-get-1 offers on its eCommerce website with a 20% discount for subscribing to monthly shipments.

"We expect this move to increase sales and margins, as well as the lifetime value of our customers due to improved customer retention," noted Pitts. "In fact, the new offer has been well received, generating a significant increase in overall subscriber growth during the first several weeks."

Looking ahead, the company anticipates strengthening performance in top-line growth, profitability, and market share expansion as its addressable markets continue to grow. This positive outlook is largely due to the anticipated launch of new products that will benefit from the broad market channels the company has strategically developed and invested in over the past several years.

According to Pitts, "These investments have proven to be the most effective way to create significant shareholder value-and this will continue to be our top priority."

The preliminary unaudited results presented in this press release are estimates only and are subject to revision until the company officially reports its quarterly results in mid-November.

HYEX: effective Dec. 29,2023 a one for 120 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

$HYEX: Great Quarterly Earnings report.... Revs up 187%

Very nice


Now at 0.055


Healthy Extracts Expects Q1 2022 Net Revenue up 187% to Record $489,000, Driving First Profitable Quarter
April 12, 2022 08:31 ET | Source: Healthy Extracts Inc.




...
LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, reported preliminary unaudited results for the first quarter ended March 31, 2022.

Net revenue for the first quarter is expected to total more than $489,000, up 187% over the same year-ago quarter, and keeps full year outlook on track for revenue to double to more than $3 million.

“Our record top-line for a first quarter resulted primarily from expansion of direct-to-consumer channels, including a four-fold increase in recurring revenue from product subscriptions,” stated Duke Pitts, president of Healthy Extracts. “We also expect this strong performance to drive our first-ever positive net income quarter.”

Over the past year, the company established a solid foundation for addressing the fast-growing brain and heart health supplement market, including key acquisitions and successful clinical studies that support its products’ health benefit claims.

“We believe the progress we have made, particularly with expanding our sales channels and portfolio of clinically proven natural products, keeps us on course for our earlier guided 100% sales growth in 2022,” added Duke. “Together with our continued focus on building our recurring revenue stream from subscriptions, we anticipate a continued strengthening of our shareholder value throughout the year.”

The preliminary unaudited results are estimates only and are subject to revision until the company reports its financial results for the first quarter ended March 31, 2022, which it expects to report in May.

About Healthy Extracts “Live Life Young Again”
Healthy Extracts Inc. is a platform for developing or acquiring science-forward, clinically proven, plant-based proprietary products in select high-growth categories within the multibillion-dollar nutraceuticals market.

The company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with healthy heart benefits backed by more than 17 clinical studies.

UBN KETONOMICS® proprietary formulations have been clinically shown to improve brain health, including memory, cognition, focus and neuro-energy. UBN is pursuing intellectual property license opportunities for monetizing its IP portfolio of multiple issued and pending patents.

For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.

Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2022, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Food and Drug Administration Disclosure

The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™

Healthy Extracts Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact

Investor Contact:
Ronald Both or Justin Lumley
CMA
Tel (949) 432-7566
Email contact

Media Contact:
Tim Randall
CMA
Tel (949) 432-7572
Email contact


GO $HYEX

$HYEX Discussing The Foundation Built on Investor Trust

WATCH>>

And a very possible RS coming

$HYEX Why You Should Be Excited About Healthy Extracts; Zero Debt
Large growth revenue year over year.
Nearly debt free.
Minimal overhead costs.

@HealthyExtracts $HYEX / #OTCQB
Launches Educational Initiative on YouTube Highlighting Clinically Proven Supplements for Heart & Brain Health.

bullish.link/BbcCG

?Healthy Extracts Inc. #OTCQB / $HYEX
?Corporate strategy to provide better lifestyles through superior health technology.

https://bullish.link/JY1Vq

Anyone else receive mail today about a Reverse Split so it ensures they stay way above a penny on the QB? Total BS

In at .06 & .0625; Changed my mind; SS & chart set up is too good to pass up

Nope, now it's waking up; wish I could buy it when the market opens in 30 minutes but putting my money into another one today that should bring more profit but this one looks ready to go! Keeping an eye on it

HYEX waking up!

I figure that when they were selling their CBD products that one of the platforms it was being sold through was cbd.co

maybe I'm reading it incorrectly, but the SEC filings show they did at one time.

HYEX does not own cbd.co , that is a marketplace like amazon that sells numerous brands of CBD

SO TRUE ,PUT LIPSTICK ON THE PIG SO IT FLYS JUST WAIT TILL FOLKS THAT GET IN DO NOTHING BUT DONATE TO THE CEO AND 3RD PARTY , BY THE LOOKS OF THE DAILY VOLUME ,LOOKS LIKE SMART TRADERS KNOW BETTER THAN TO PUT A PENNY IN THIS POS HYEX......

I agree - there's the saying 'pig with lipstick'. I know a lot of companies that change their name, yet stay exactly the same - like jiffy lube.

I don't want to stay around a schlocky company. You helped me find my way to greener pastures. I thank you for it.

The issue is now - should I avoid buying their product, as it can be funding their cbd.co website. They did say healthy extracts is a revenue source to fund their cbd operations.

Idk what third party you're referring to, but what I read looks like it's related to their debts.

AS A ANIMAL GET'S OLDER ,THEY NEVER CHANGE THEIR STRIPS I HIGHLY DOUBT THIS TICKER (NEW TICKER) WILL BE ANY DIFFERENT THAN ANY OF THEIR OTHER TICKERS ,CEO AND THIRD PARTY ARE TOO GREEDY.

HANG AROUND FER THE NEXT 90 DAYS OR SO AND YOU WILL SEE EXACTLY WHAT I'M SAYING "

WE ALL TRADE WHAT WE WANT BY CHOICE ,I'M NOT A FINANCIAL ADVISOR AND NEV ER ADVISE ANYONE ON WHAT TO DO WITH THEIR MONEY IN THE OTC MARKET BUT I'M VERY FAMILIAR WITH THE CEO AND THIRD PARTY HERE AND KNOW ALL THEY CARE ABOUT IS SELLING SHARES PERIOD.

THESE ARE JUST THE FACTS AS I KNOW THEM.

company used to own cbd.co

https://sec.report/Document/0001520138-18-000125/

This is not vegan - products have gelatin in it.

The website's still running, so they're still selling it!

true - thanks for the warning!

I don't see the 'constant' pump and dump - the issue is the person who did a pump and dump back in 2017-2018 is still there.

What you're saying is that they haven't changed their ways.

What about how it became a different company - isn't it legitimate now?

I'm just an average investor - a confused one at that.

I looked up the R/S - looks like it happened twice between 2017 and 2018, but seems to be associated with conversions of the Series A to a stock https://sec.report/Document/0001520138-20-000130/

I see your point about the CEO being a part of the cannabis business and is still there though. I don't like associating with cannabis.

AND 0.066 IS EVEN CHEAPER LOL -) GET A SCORE BEFORE THIS GETS DILUTED DOWN LIKE IT HAS BEEN FER YEARS AND YEARS.

Healthy Extracts Inc (HYEX)
0.066 ? 0.0 (0.00%)
Volume: 0 @-

AND THESE CLOWNS STILL WON'T DO ANYTHING EXCEPT DILUTE SHARES TO THE PUBLIC AND THEN WHEN THE STOCK RUNS OUT AND THE PPS PLUMETS ,JUST DO A R/S TO DO IT ALL OVER AGAIN.

LOOK BACK AT THE HISTORY OF THE CEO AND THE COMPANY, IT'S BEEN A PUMP AND DUMP FER YEARS ,IT'S NO SECRET ,I HOPE YOU GUYS MAKE A TON ,IT'S JUST KINDA DOUBTFUL TO BE HONEST..

MAYBE GET THEM EYES OPEN AND DO SOME REAL DD? THIS CEO HAS BEEN MAKING THIS A THIRD PARTY MONEY GRAB FER YEARS.

DID YA EVER LOOK AT HOW MANY TIMES A R/S WAS DONE?

DID YA LOOK AT WHEN THE PRICE WAS 0.50 AND AFTER A FEW MONTHS THE PPS WAS SUB PENNY?

YES THIS STOCK IS NOTHING MORE OR LESS A SCAM AND NEVER ,YES NEVER DO THEY DO ANYTHING THE NEWS SAYS ,IT'S A CONSTANT PUMP & DUMP!

they closed their CBD/hemp oil business due to not making money. I don't see the issue in it being a CBD play, as it's no longer a part of it and was for pharmaceutical purposes anyway https://sec.report/Document/0001520138-21-000113/

I see no issues on their filing https://sec.report/Ticker/hyex

why is everyone calling this a scam and no one's buying it while articles are saying it'll go up https://www.globenewswire.com/news-release/2020/10/20/2111069/0/en/Grey-Cloak-Tech-Inc-Releases-Independent-Report.html

One thought is that no one knows about this stock. Anyone else?

how is youngevity related to healthy extracts?

what is the scam? I don't see it

Lots going on here behind the scenes. That's fantastic!!

These clowns haven't done anything in 5 years. I wouldn't risk investing here. I am just waiting for it to go up and recover what I have from 5 years ago.

HYEX .07 chreap imo

https://healthyextractsinc.com/

Key 2020 Activities:

Gross revenue was up 71% in 2020, even with some continued negative effects of COVID.
Healthy Extracts Inc. (HYEX) name change from Grey Cloak Tech to better align its companies.
Full reporting and upgraded to the OTCQB in October 2020.
Independent report conducted by Trickle Research projecting positive stock growth.
Company eliminated all convertible debt.
Net shareholder equity increase of $3.7 million.
Acquired Ultimate Brain Nutrients for its breakthrough brain products, including six patents (2 issued, 4 pending) and its proprietary formulations.
Introduction of the revolutionary Clinical Immune, the only immune product formulated and clinically proven focusing on heart and respiratory immune health.
Key clinical studies on its proprietary unique Fuel4Thought Brain Booster product, with sales beginning in Q2.
Pilot study completed on the Company’s Fuel4Thought Migraine formulation with great results; study was published in the renowned World Journal of Advanced Research and Reviews.
Release of HerHeart, the only cardiovascular product designed just for women; positive clinical trial results published in Annals of Women's Health. Cardiovascular disease is and will likely remain the No. 1 cause of death in the U.S. for women and men.

Maybe we start to see some action here.

Grey Cloak Tech Inc., GRCK, changed to Healthy Extracts Inc., HYEX:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Name change.... interesting, definitely a name that aligns with their products

Awesome ????????

Name and symbol change on DL https://otce.finra.org/otce/dailyList

THE LARGER THE VOLUME THE LOWER AND LOWER THE PPS GOES ,SHOCKED THIS POS IS STILL NOT SUSPENDED.

no, I have no affiliation with the company

Are you the ceo or third party?

No not 3rd party. I agree no one should trade with blind eye. I have made my money off this stock and have moved on to other opportunities, I suggest you do the same

SEEING THAT ALL 8 OF YOUR POSTS ARE ON THE GRCK BOARD ,ARE YOU MANAGEMENT OR 3RD PARTY ,NOT EVERYONE TRADES WITH A BLIND EYE "

I CAN SEE HOW YOU DID SO WELL ,THE VOLUME IS ALWAYS INCREDIBLE

OH LOOKIE A NEW GRCK POSTER THATS POSTING COMPANY INFO TO GAIN VOLUME ,VOLUME IS STILL PATHETIC "

GRCK HAS NEVER BEEN ANYTHING BUT A SHARE SELLING SCAM.......... NUTTIN CHANGED.....

BOB ,THEY NEVER HAVE REAL REVS ,THIS IS A CEO THAT SELLS STOCK THROUGH THIRD PARTIES TO MAKE HIS MONEY ,NOTHING MORE AND NOTHING LESS!!!!!!!!

BOB , HOW COME THERE IS NEVER SIGNIFICANT MONEY FLOW OR VOLUME HERE IF IT'S SOOOOO GREAT

$GRCK Grey Cloak Tech Inc. Subsidiary BergaMet NA™ Announces Sales Agreement with Major Key Account, Xymogen® https://finance.yahoo.com/news/grey-cloak-tech-inc-subsidiary-133000748.html?.tsrc=fin-srch